Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Jeffrey Olson

Concepts (319)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Vitreous Body
14
2020
104
3.200
 Why?
Ophthalmologic Surgical Procedures
5
2017
60
2.350
 Why?
Angiogenesis Inhibitors
11
2022
219
2.140
 Why?
Retina
11
2016
278
1.830
 Why?
Glaucoma
4
2017
202
1.740
 Why?
Alloys
4
2013
31
1.730
 Why?
Eye Foreign Bodies
5
2016
23
1.720
 Why?
Macular Edema
4
2022
36
1.670
 Why?
Retinal Detachment
6
2019
54
1.630
 Why?
Vitrectomy
7
2019
58
1.590
 Why?
Diabetic Retinopathy
6
2019
160
1.560
 Why?
Glaucoma Drainage Implants
3
2016
47
1.510
 Why?
Retinal Diseases
5
2017
81
1.350
 Why?
Intraocular Pressure
7
2017
275
1.330
 Why?
Nanopores
2
2020
4
1.310
 Why?
Intravitreal Injections
7
2022
46
1.280
 Why?
Membranes, Artificial
2
2020
70
1.260
 Why?
Nanotechnology
2
2020
120
1.180
 Why?
Suction
3
2015
32
1.100
 Why?
Sutures
3
2015
61
1.030
 Why?
Choroidal Neovascularization
4
2011
44
1.030
 Why?
Anterior Eye Segment
2
2017
10
1.030
 Why?
Swine
10
2017
730
1.000
 Why?
Suture Techniques
3
2015
134
0.990
 Why?
Equipment Design
6
2017
519
0.970
 Why?
Lens Implantation, Intraocular
2
2015
60
0.940
 Why?
Retinitis
1
2022
17
0.870
 Why?
Retinal Vasculitis
1
2022
7
0.870
 Why?
Aneurysm
1
2022
32
0.850
 Why?
Antibodies, Monoclonal
6
2020
1284
0.800
 Why?
Vitreoretinopathy, Proliferative
2
2019
12
0.800
 Why?
Vascular Endothelial Growth Factor A
6
2020
527
0.770
 Why?
Immunosuppressive Agents
3
2013
681
0.760
 Why?
Retinal Vessels
2
2015
53
0.760
 Why?
Durapatite
1
2020
33
0.750
 Why?
Cytomegalovirus Retinitis
2
2013
13
0.750
 Why?
Disease Models, Animal
8
2020
3730
0.730
 Why?
Complement System Proteins
2
2020
294
0.730
 Why?
Eye Injuries, Penetrating
3
2016
17
0.730
 Why?
Isoxazoles
2
2013
56
0.720
 Why?
Endophthalmitis
2
2017
25
0.720
 Why?
Scleral Buckling
3
2012
18
0.720
 Why?
Stents
2
2013
457
0.690
 Why?
Fluorocarbons
2
2012
105
0.630
 Why?
Anterior Chamber
1
2017
21
0.610
 Why?
Transducers
1
2017
27
0.600
 Why?
Glucocorticoids
2
2020
545
0.600
 Why?
Strabismus
1
2017
27
0.600
 Why?
Sclera
2
2015
36
0.580
 Why?
Filtering Surgery
1
2016
22
0.570
 Why?
Trabeculectomy
1
2017
65
0.560
 Why?
Surgical Instruments
2
2013
49
0.560
 Why?
Fovea Centralis
2
2006
8
0.560
 Why?
Ocular Hypertension
1
2016
60
0.540
 Why?
Laser Therapy
1
2017
104
0.540
 Why?
Retinal Perforations
2
2005
14
0.540
 Why?
Drug Resistance, Multiple, Viral
2
2013
11
0.540
 Why?
Ophthalmology
2
2013
80
0.530
 Why?
Lenses, Intraocular
1
2015
45
0.520
 Why?
Tomography, Optical Coherence
7
2015
126
0.520
 Why?
Lasers
1
2015
124
0.520
 Why?
Monitoring, Physiologic
1
2017
272
0.510
 Why?
Device Removal
1
2016
127
0.500
 Why?
Prostheses and Implants
1
2016
141
0.500
 Why?
Antiviral Agents
2
2013
654
0.490
 Why?
Fluorescein Angiography
9
2012
103
0.490
 Why?
Ischemia
2
2017
374
0.490
 Why?
Rabbits
3
2020
780
0.470
 Why?
Models, Cardiovascular
1
2015
180
0.470
 Why?
Retinal Degeneration
2
2015
31
0.460
 Why?
Animals
18
2020
33381
0.460
 Why?
Artificial Lens Implant Migration
1
2013
3
0.460
 Why?
Choroid
3
2015
47
0.460
 Why?
Macular Degeneration
6
2015
151
0.450
 Why?
Viscosupplements
1
2012
10
0.450
 Why?
Gravitation
1
2012
21
0.450
 Why?
Silicone Oils
1
2012
25
0.440
 Why?
Silicon
1
2012
14
0.440
 Why?
Pupil Disorders
1
2012
5
0.440
 Why?
Eye Enucleation
1
2012
12
0.440
 Why?
Iris
1
2012
19
0.440
 Why?
Viremia
1
2013
132
0.430
 Why?
Quantum Dots
1
2012
34
0.430
 Why?
Silicone Elastomers
1
2012
7
0.430
 Why?
Uveitis, Posterior
1
2012
12
0.420
 Why?
Surgical Stapling
1
2012
9
0.420
 Why?
Prosthesis Implantation
1
2013
141
0.420
 Why?
Fluocinolone Acetonide
1
2012
16
0.420
 Why?
Vitreous Hemorrhage
2
2015
6
0.410
 Why?
Cataract Extraction
1
2013
82
0.410
 Why?
Electric Stimulation Therapy
1
2012
74
0.400
 Why?
Vascular Endothelial Growth Factors
1
2011
67
0.400
 Why?
Models, Biological
4
2015
1715
0.390
 Why?
Oxygen
1
2015
854
0.370
 Why?
Cytomegalovirus
2
2013
144
0.370
 Why?
Materials Testing
1
2012
359
0.360
 Why?
Humans
47
2022
118974
0.360
 Why?
Anti-Inflammatory Agents
1
2012
465
0.320
 Why?
Interleukin 1 Receptor Antagonist Protein
1
2009
256
0.320
 Why?
Biocompatible Materials
1
2012
378
0.310
 Why?
Electroretinography
5
2016
41
0.310
 Why?
von Hippel-Lindau Disease
1
2007
12
0.300
 Why?
Antibodies, Monoclonal, Humanized
6
2015
667
0.290
 Why?
Pigment Epithelium of Eye
2
2006
34
0.290
 Why?
Injections
5
2012
167
0.290
 Why?
Drug Implants
2
2020
72
0.290
 Why?
Puerperal Disorders
1
2007
33
0.290
 Why?
Recombinant Fusion Proteins
4
2022
653
0.280
 Why?
Uveal Diseases
1
2006
5
0.280
 Why?
Ocular Hypotension
1
2006
10
0.280
 Why?
Fusobacterium Infections
1
2006
6
0.280
 Why?
Pharyngeal Diseases
1
2006
15
0.280
 Why?
Epiretinal Membrane
1
2005
6
0.280
 Why?
Visual Acuity
7
2019
272
0.280
 Why?
Ciliary Body
1
2006
33
0.280
 Why?
Needles
2
2017
56
0.280
 Why?
Dementia
2
2022
208
0.270
 Why?
Telangiectasis
1
2005
6
0.270
 Why?
Female
26
2022
61565
0.270
 Why?
Rats, Inbred BN
3
2011
53
0.270
 Why?
Uveitis
1
2006
116
0.260
 Why?
Receptors, Vascular Endothelial Growth Factor
3
2022
103
0.260
 Why?
Kidney Transplantation
2
2013
585
0.250
 Why?
Injections, Intraocular
2
2015
10
0.250
 Why?
Polypropylenes
2
2015
17
0.240
 Why?
Middle Aged
17
2019
27617
0.240
 Why?
Autoimmune Diseases
1
2006
398
0.220
 Why?
Laser Coagulation
3
2012
55
0.220
 Why?
Bevacizumab
6
2015
124
0.220
 Why?
Optic Atrophy
1
2022
11
0.220
 Why?
Hearing Loss, Central
1
2022
6
0.220
 Why?
Retinal Vein Occlusion
2
2015
13
0.200
 Why?
Cell Count
2
2012
315
0.200
 Why?
Rats
4
2012
5392
0.200
 Why?
Dialysis
1
2020
24
0.190
 Why?
Leukemia, Megakaryoblastic, Acute
1
2000
11
0.190
 Why?
Orbital Neoplasms
1
2000
21
0.190
 Why?
Male
21
2019
57801
0.190
 Why?
Adult
11
2022
31512
0.180
 Why?
Adsorption
1
2020
129
0.180
 Why?
Time Factors
4
2017
6412
0.180
 Why?
Follow-Up Studies
5
2015
4596
0.180
 Why?
Biomarkers
2
2020
3588
0.180
 Why?
Wet Macular Degeneration
1
2019
32
0.170
 Why?
Geographic Atrophy
1
2019
49
0.160
 Why?
Fluorescein-5-isothiocyanate
2
2009
38
0.160
 Why?
Eye Diseases, Hereditary
1
2018
13
0.160
 Why?
Miniaturization
2
2015
24
0.160
 Why?
Dextrans
2
2009
74
0.160
 Why?
Iris Diseases
1
2017
5
0.150
 Why?
Choroid Diseases
1
2017
9
0.150
 Why?
Glomerulonephritis, Membranoproliferative
1
1997
14
0.150
 Why?
Enzyme-Linked Immunosorbent Assay
1
2019
827
0.150
 Why?
Dark Adaptation
2
2012
13
0.150
 Why?
Hypertension
1
2006
1203
0.150
 Why?
Antimony
1
2016
5
0.150
 Why?
Aged, 80 and over
6
2019
6561
0.140
 Why?
Infliximab
2
2007
94
0.140
 Why?
Pressure
1
2017
226
0.140
 Why?
Dose-Response Relationship, Drug
3
2014
1945
0.140
 Why?
Aged
10
2020
19657
0.140
 Why?
Sclerostomy
1
2015
4
0.140
 Why?
Polymers
1
2020
482
0.140
 Why?
Treatment Outcome
9
2016
9342
0.140
 Why?
Foreign-Body Migration
1
2016
37
0.140
 Why?
Gyrate Atrophy
1
2015
2
0.130
 Why?
Vitreoretinal Surgery
1
2015
3
0.130
 Why?
Eye Infections, Bacterial
1
2015
26
0.130
 Why?
Stress, Mechanical
1
2017
443
0.130
 Why?
Vitreous Detachment
1
2015
6
0.130
 Why?
Diagnostic Techniques, Ophthalmological
1
2015
36
0.130
 Why?
Down Syndrome
1
2000
356
0.130
 Why?
Health Knowledge, Attitudes, Practice
2
2014
1185
0.130
 Why?
Partial Pressure
1
2015
29
0.130
 Why?
Equipment Failure Analysis
1
2015
139
0.130
 Why?
Hemoglobin SC Disease
1
2015
15
0.130
 Why?
Feedback
1
2015
153
0.130
 Why?
Biopsy, Needle
1
2015
190
0.130
 Why?
Prosthesis Failure
1
2016
120
0.130
 Why?
Oculomotor Muscles
1
2014
42
0.130
 Why?
International Normalized Ratio
1
2014
45
0.130
 Why?
Protein Binding
1
2020
1975
0.120
 Why?
Postoperative Care
1
2015
237
0.120
 Why?
Exchange Transfusion, Whole Blood
1
2013
18
0.120
 Why?
Retinal Artery Occlusion
1
2013
8
0.120
 Why?
Diabetes Mellitus, Type 2
2
2012
2174
0.120
 Why?
Warfarin
1
2014
139
0.120
 Why?
In Vitro Techniques
1
2015
1094
0.120
 Why?
Tendons
1
2014
137
0.110
 Why?
Metabolomics
1
2018
550
0.110
 Why?
Specific Gravity
1
2012
13
0.110
 Why?
Transducers, Pressure
1
2012
15
0.110
 Why?
Adaptation, Ocular
1
2012
4
0.110
 Why?
Erythrocyte Transfusion
1
2015
210
0.110
 Why?
Research Design
1
2019
969
0.110
 Why?
Minerals
1
2012
39
0.110
 Why?
Rats, Mutant Strains
1
2012
25
0.110
 Why?
Viscosity
1
2012
83
0.110
 Why?
Pupil
1
2012
13
0.110
 Why?
Antineoplastic Agents
2
2020
1974
0.110
 Why?
Corneal Endothelial Cell Loss
1
2012
2
0.110
 Why?
Acetates
1
2012
98
0.110
 Why?
Endothelium, Corneal
1
2012
12
0.110
 Why?
Adolescent
4
2019
18480
0.110
 Why?
Retinal Neovascularization
1
2012
21
0.110
 Why?
Sodium Chloride
1
2012
144
0.100
 Why?
Swine, Miniature
1
2012
71
0.100
 Why?
Drug Combinations
1
2012
291
0.100
 Why?
Microsurgery
1
2012
64
0.100
 Why?
Electrodes, Implanted
1
2012
97
0.100
 Why?
Retinal Ganglion Cells
1
2012
92
0.100
 Why?
Tumor Necrosis Factor-alpha
2
2007
1171
0.100
 Why?
Gold
1
2012
102
0.100
 Why?
Bruch Membrane
1
2011
6
0.100
 Why?
Polyglycolic Acid
1
2011
44
0.100
 Why?
Registries
1
2019
1810
0.100
 Why?
Administration, Oral
1
2013
756
0.100
 Why?
Drug Compounding
1
2011
90
0.100
 Why?
Dissection
1
2011
55
0.090
 Why?
Delayed-Action Preparations
1
2011
161
0.090
 Why?
Retrospective Studies
8
2015
12978
0.090
 Why?
Atrial Fibrillation
1
2014
338
0.090
 Why?
Computer Simulation
1
2015
922
0.090
 Why?
Anemia, Sickle Cell
1
2013
230
0.090
 Why?
Models, Animal
1
2012
363
0.090
 Why?
Lactic Acid
1
2011
282
0.090
 Why?
Cell Survival
1
2012
1047
0.080
 Why?
Bacteria
1
2015
757
0.080
 Why?
Scotoma
1
2008
4
0.080
 Why?
Proliferating Cell Nuclear Antigen
1
2007
55
0.080
 Why?
Optic Neuropathy, Ischemic
1
2007
29
0.080
 Why?
Papilledema
1
2007
36
0.080
 Why?
Pilot Projects
1
2012
1419
0.070
 Why?
Severity of Illness Index
2
2014
2674
0.070
 Why?
Visual Fields
3
2007
78
0.070
 Why?
RNA, Catalytic
1
2007
182
0.070
 Why?
Retinitis Pigmentosa
1
2006
17
0.070
 Why?
Glycogen Storage Disease Type IIb
1
2006
20
0.070
 Why?
Triamcinolone Acetonide
1
2006
24
0.070
 Why?
Fusobacterium necrophorum
1
2006
1
0.070
 Why?
Young Adult
2
2019
10793
0.070
 Why?
Polyethylene Glycols
1
2011
578
0.070
 Why?
Indocyanine Green
1
2005
13
0.070
 Why?
Vision, Low
3
2013
14
0.070
 Why?
Myopia
1
2006
37
0.070
 Why?
Coloring Agents
1
2005
73
0.070
 Why?
Eye Injuries
1
2006
46
0.070
 Why?
Infusions, Intravenous
1
2006
380
0.070
 Why?
Staining and Labeling
1
2005
146
0.070
 Why?
Syndrome
1
2006
344
0.060
 Why?
Cataract
1
2006
194
0.060
 Why?
Multivariate Analysis
2
2019
1474
0.060
 Why?
Diagnosis, Differential
1
2007
1384
0.050
 Why?
Ranibizumab
2
2013
18
0.050
 Why?
Blindness
2
2013
35
0.050
 Why?
Postoperative Complications
1
2012
2235
0.050
 Why?
Keratitis
1
2000
13
0.050
 Why?
Exophthalmos
1
2000
19
0.050
 Why?
Chronic Disease
1
2006
1636
0.040
 Why?
Immunophenotyping
1
2000
278
0.040
 Why?
Tomography, X-Ray Computed
2
2016
2436
0.040
 Why?
Xanthine
1
2018
8
0.040
 Why?
Combined Modality Therapy
2
2013
1166
0.040
 Why?
Electrooculography
1
1997
11
0.040
 Why?
Visual Field Tests
1
1997
14
0.040
 Why?
Color Vision Defects
1
1997
6
0.040
 Why?
Fundus Oculi
1
1997
41
0.040
 Why?
Purines
1
2018
161
0.040
 Why?
Cohort Studies
2
2019
5116
0.040
 Why?
Child
2
2015
19129
0.040
 Why?
Photic Stimulation
1
1997
204
0.040
 Why?
Odds Ratio
1
2019
996
0.030
 Why?
Vision Disorders
1
1997
135
0.030
 Why?
Microbiological Techniques
1
2015
31
0.030
 Why?
Myopia, Degenerative
1
2015
3
0.030
 Why?
Colony Count, Microbial
1
2015
120
0.030
 Why?
Endotamponade
1
2015
4
0.030
 Why?
Tenon Capsule
1
2014
3
0.030
 Why?
Metabolome
1
2018
296
0.030
 Why?
Tissue Adhesions
1
2015
31
0.030
 Why?
Mass Spectrometry
1
2018
681
0.030
 Why?
Disease Progression
2
2015
2490
0.030
 Why?
Photography
1
2015
93
0.030
 Why?
Pregnancy
1
2007
5691
0.030
 Why?
Atrophy
1
2015
164
0.030
 Why?
Biometry
1
2014
65
0.030
 Why?
Conjunctiva
1
2014
52
0.030
 Why?
Risk Factors
2
2019
9000
0.030
 Why?
Glucose
1
2018
953
0.030
 Why?
Fatty Acids, Omega-3
1
2014
125
0.030
 Why?
Retreatment
1
2012
71
0.030
 Why?
Risk Assessment
2
2014
3057
0.030
 Why?
Kaplan-Meier Estimate
1
2014
842
0.030
 Why?
Oxidative Stress
1
2018
1178
0.030
 Why?
Global Health
1
2014
310
0.030
 Why?
Proportional Hazards Models
1
2014
1125
0.020
 Why?
Survival Analysis
1
2014
1267
0.020
 Why?
Phenotype
1
2019
3003
0.020
 Why?
Health Care Costs
1
2014
394
0.020
 Why?
Antioxidants
1
2014
564
0.020
 Why?
Anticoagulants
1
2014
559
0.020
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2014
387
0.020
 Why?
Clinical Trials, Phase II as Topic
1
2009
57
0.020
 Why?
Clinical Trials, Phase I as Topic
1
2009
47
0.020
 Why?
Comorbidity
1
2014
1527
0.020
 Why?
Colorado
1
2019
4196
0.020
 Why?
Prospective Studies
2
2012
6471
0.020
 Why?
Retinal Artery
1
2007
15
0.020
 Why?
Cerebral Angiography
1
2007
116
0.020
 Why?
Infant
1
2000
8293
0.020
 Why?
Lysosomal-Associated Membrane Protein 2
1
2006
24
0.020
 Why?
Frameshift Mutation
1
2006
28
0.020
 Why?
Prognosis
1
2014
3443
0.020
 Why?
Secondary Prevention
1
2007
227
0.020
 Why?
Anti-Bacterial Agents
1
2015
1510
0.020
 Why?
Adrenal Cortex Hormones
1
2008
521
0.020
 Why?
Double-Blind Method
1
2007
1687
0.010
 Why?
RNA, Messenger
1
2007
2657
0.010
 Why?
Aging
1
2008
1670
0.010
 Why?
Olson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (319) concept(s)
_
Co-Authors Expand Description
See all (23) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)